Synthesis of Branched Arabinogalactans Up to a 140-Mer from Panax Notoginseng and Their Anti-Pancreatic-cancer Activity

Xianjin Qin,Chenghao Xu,Mingli Liu,Fansheng Zeng,Wenlong Yao,Yi Deng,Tianfu Xu,Shengyuan Sun,Dongyue Sun,Juan Mo,Xin-Shan Ye
DOI: https://doi.org/10.1038/s44160-023-00428-x
2024-01-01
Nature Synthesis
Abstract:RN1, a highly branched arabinogalactan isolated from the flower of Panax notoginseng , possesses a potent ability to inhibit the development of pancreatic cancer. Due to the structural complexity and heterogeneity of RN1, it is difficult to extract homogeneous RN1 from natural sources. The structure–activity relationship is ambiguous, particularly the correlation between molecular size and function. We report the total synthesis of the RN1 glycan featuring 140 monosaccharide units via an efficient iterative preactivation-based one-pot glycosylation strategy, providing an intact complex polysaccharide, allowing investigation of its structure–activity relationship. Using this glycosylation strategy, a glycan library comprising nine molecules was constructed, ranging from 5-mer to 140-mer. Finally, all compounds in the library were screened for anti-pancreatic-cancer activity via detection of cell proliferation, apoptosis and cell cycle. The active structural domain of RN1 was revealed to be a decasaccharide fragment that exhibited superior performance compared to gemcitabine, a frequently used anti-pancreatic-cancer drug.
What problem does this paper attempt to address?